Cite
HARVARD Citation
Burmester, G. et al. (2013). FRI0232 Consistent efficacy and safety outcomes between european and japanese subjects with rheumatoid arthritis following treatment with mavrilimumab in the phase 2 earth study. Annals of the rheumatic diseases. pp. A451-A452. [Online].